» Articles » PMID: 28871310

Autophagy in Diabetic Kidney Disease: Regulation, Pathological Role and Therapeutic Potential

Overview
Publisher Springer
Specialty Biology
Date 2017 Sep 6
PMID 28871310
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic kidney disease, a leading cause of end-stage renal disease, has become a serious public health problem worldwide and lacks effective therapies. Autophagy is a highly conserved lysosomal degradation pathway that removes protein aggregates and damaged organelles to maintain cellular homeostasis. As important stress-responsive machinery, autophagy is involved in the pathogenesis of various diseases. Emerging evidence has suggested that dysregulated autophagy may contribute to both glomerular and tubulointerstitial pathologies in kidneys under diabetic conditions. This review summarizes the recent findings regarding the role of autophagy in the pathogenesis of diabetic kidney disease and highlights the regulation of autophagy by the nutrient-sensing pathways and intracellular stress signaling in this disease. The advances in our understanding of autophagy in diabetic kidney disease will facilitate the discovery of a new therapeutic target for the prevention and treatment of this life-threatening diabetes complication.

Citing Articles

Evolutionary patterns and research frontiers in autophagy in podocytopathies: a bibliometric analysis.

Liu F, Xu Z, Chen G, Xu X, Cao H, Chen J Front Med (Lausanne). 2025; 11():1445550.

PMID: 39850100 PMC: 11754056. DOI: 10.3389/fmed.2024.1445550.


The ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol is associated with diabetic kidney disease: A cross-sectional study.

Zhang L, Fan D, Zhu T, Geng L, Gan L, Ou S PLoS One. 2024; 19(11):e0311620.

PMID: 39602386 PMC: 11602080. DOI: 10.1371/journal.pone.0311620.


Mesenchymal Stem Cell Therapy: Therapeutic Opportunities and Challenges for Diabetic Kidney Disease.

Cheng J, Zhang C Int J Mol Sci. 2024; 25(19).

PMID: 39408867 PMC: 11477055. DOI: 10.3390/ijms251910540.


Corilagin alleviates podocyte injury in diabetic nephropathy by regulating autophagy the SIRT1-AMPK pathway.

Lou Y, Luan Y, Rong W, Gai Y World J Diabetes. 2024; 15(9):1916-1931.

PMID: 39280180 PMC: 11372637. DOI: 10.4239/wjd.v15.i9.1916.


Identification and Validation of the miR/RAS/RUNX2 Autophagy Regulatory Network in AngII-Induced Hypertensive Nephropathy in MPC5 Cells Treated with Hydrogen Sulfide Donors.

Ye Q, Ren M, Fan D, Mao Y, Zhu Y Antioxidants (Basel). 2024; 13(8).

PMID: 39199205 PMC: 11351630. DOI: 10.3390/antiox13080958.


References
1.
Qi W, Mu J, Luo Z, Zeng W, Guo Y, Pang Q . Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response. Metabolism. 2010; 60(5):594-603. DOI: 10.1016/j.metabol.2010.07.021. View

2.
Lenoir O, Jasiek M, Henique C, Guyonnet L, Hartleben B, Bork T . Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis. Autophagy. 2015; 11(7):1130-45. PMC: 4590611. DOI: 10.1080/15548627.2015.1049799. View

3.
Colman R, Anderson R, Johnson S, Kastman E, Kosmatka K, Beasley T . Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009; 325(5937):201-4. PMC: 2812811. DOI: 10.1126/science.1173635. View

4.
He C, Klionsky D . Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009; 43:67-93. PMC: 2831538. DOI: 10.1146/annurev-genet-102808-114910. View

5.
Chuang P, Dai Y, Liu R, He H, Kretzler M, Jim B . Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus. PLoS One. 2011; 6(8):e23566. PMC: 3157434. DOI: 10.1371/journal.pone.0023566. View